Table 2 Infant- and Jaundice- Related Characteristics in the Study and Control Groups
Variable | No Readmission Control Group (N = 100) | Readmission Study Group (N = 100) | p Value | ||
|---|---|---|---|---|---|
Female, n | 49 | (49%) | 41 | (41%) | 0.26 |
Birth weight, gr, mean (SD) | 3201.0 | (434.7) | 3163.3 | (416.7) | 0.53 |
Gestational age (weeks), median (Q1, Q3) | 38.0 | (37.0, 39.0) | 38.0 | (37.0, 39.0) | 1.00 |
Late preterm neonate (< 37), n | 8 | (8%) | 8 | (8%) | 1.00 |
Size for gestational age, n (%) | 0.41 | ||||
Appropriate | 81 | (81%) | 86 | (86%) | |
Large | 15 | (15%) | 9 | (9%) | |
Small | 4 | (4%) | 5 | (5%) | |
G6PD deficiency, n (%) | 14 | (14%) | 14 | (14%) | 1.00 |
Apgar 1 (range 5–7), n | 7 | (7%) | 2 | (2%) | 0.09 |
Apgar 5 (range 5–7), n | 1 | (1%) | 0 | (0%) | 0.32 |
Feeding, n | 0.11 | ||||
Breastfeeding | 49 | (49%) | 51 | (51%) | 0.78 |
Mixed | 39 | (39%) | 45 | (45%) | NS |
Formula | 12 | (12%) | 4 | (4%) | 0.037 |
Postnatal LOS, median (Q1, Q3) | 4.0 | (3.0, 5.0) | 2.0 | (2.0, 3.0) | < 0.001 |
Weight loss > 5% n (%) | 42 | (42%) | 57 | (57%) | 0.034 |
Laboratory findings during first hospitalization | |||||
Highest value of total bilirubin, umol/L, mean (SD) | 13.4 | (2.3) | 11.9 | (2.9) | < 0.001 |
Hemoglobin, g/dl, median (Q1, Q3) | 17.6 | (16.0, 19.2) | 19.6 | (18.8, 21.4) | < 0.001 |
Hematocrit (%), median (Q1, Q3) | 53.0 | (48.0, 58.0) | 59.0 | (56.0, 63.0) | < 0.001 |
Reticulocyte > 5%, n | 40 | (40%) | 9 | (9%) | < 0.001 |
Highest value of total bilirubin during second hospitalization | . | 17.9 | (1.8) | . | |
Visits to jaundice clinic, median (Q1, Q3) | 1.0 | (0.0, 2.0) | 3.0 | (2.0, 4.0) | < 0.001 |
Phototherapy during first hospitalization, n | 63 | (63%) | 10 | (10%) | < 0.001 |